Company Long-Term Loans and Borrowings: Ocean Bio (OCEA)
Ocean Biomedical, Inc. (OCEA) revenues rely on the sale of rights to innovative methods for combating fibrosis, oncology, and malaria, including partnership royalties. Production capacities are currently utilized in ongoing clinical trials. This chart illustrates the long-term debt dynamics, which stand at 0.00. However, the risk of capital fragmentation and intense pressure from major laboratories create significant challenges for business development.
Ocean Bio (OCEA) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Ocean Biomedical, Inc.|OCEA - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Ocean Biomedical Corp|OCEA - Company Debts|Debt to Book Value Ocean Biomedical|OCEA - Company Long-Term Debt|Company Current Liabilities Ocean Biomedical|Quick Ratio oceanbiomedical.com
- earnings and multiples data:
Analysis of all company metrics:OCEA - oceanbiomedical.com
This indicator captures the total volume of long-term liabilities, reflecting the actual credit burden on the balance sheet. For Ocean Biomedical, Inc. (OCEA), which delegates clinical trials to external CRO partners, this metric determines the cost of financing outsourcing. By analyzing the company's long-term debt history, an investor can see the pace of loan accumulation. The dynamics of these liabilities reveal the risk of overpaying on loans, allowing for an assessment of the overall financial stability of the capital.
Competitors of Ocean Biomedical, Inc. (OCEA)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|ZBIO - Company Long-Term Debt|Long-Term Debt Immunome Bio|GOSS: Company Long-Term Debts|Company Long-Term Liabilities kalvista.com|SEPN (Septerna) - Company Long-Term Debts|Long-Term Debt Pieris Pharma PVLA|Company Long-Term Debts SVRA|Company Long-Term Debts Rigel Corp (RIGL)|Company Long-Term Debt AnaptysBio, Inc. ANAB|ATXS: Company Long-Term Indebtedness|ENGN: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings RAPT (rapt.com)|JBIO: Company Long-Term Debts|ACRS (Aclaris Therapeutics, Inc) - Company Long-Term Debt|KYTX (Kyverna Therapeutics) - Company Long-Term Debts|tizianalifesciences.com (TLSA) - Long-Term Debt Volume|Company Long-Term Debt Cabaletta Bio (CABA)|VTYX - Long-Term Debt|Company Long-Term Debt Theratechnologies Inc THTX|AVTX - Company Long-Term Liabilities|Eledon Pharmaceuticals - Company Long-Term Debts|Long-Term Debt agenusbio.com|CLYM: Company Long-Term Debts|Company Long-Term Indebtedness ZURA|ATYR (aTyr) - Company Long-Term Debts|Adagene Corp (ADAG) - Long-Term Debt Volume|Company Long-Term Debts IMA|Company Long-Term Liabilities shattucklabs.com STTK|Company Long-Term Debts EQ (Equillium)|Company Long-Term Debts Connect Biopharma Holdings CNTB|IMUX - Company Long-Term Debt|ATRA: Company Long-Term Debt|IFRX (inflarx.de) - Company Long-Term Liabilities|x4pharma.com - Company Long-Term Loans and Borrowings|ACET (Adicet Bio Inc.) - Company Long-Term Debts|Celularity Corp (CELU) - Long-Term Debt Volume|Company Long-Term Debt INmune Bio Corp (INMB)|Barinthus Biotherapeutics Corp - Company Long-Term Indebtedness|Company Long-Term Debts KZR (Kezar Life Sciences)|SABS - Company Long-Term Liabilities|AKTX: Company Long-Term Liabilities|Long-Term Debt Volume Enlivex Therapeutics ENLV|q32bio.com (QTTB) - Company Long-Term Debt|Long-Term Debt GeoVax Corp (GOVX)|EDSA (Edesa Biotech, Inc.) - Company Long-Term Debts|Company Long-Term Liabilities ibioinc.com (IBIO)|Company Long-Term Debts CARM|XTLB - Long-Term Debt|Company Long-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Long-Term Debts HCW Biologics, Inc. HCWB|APVO - Company Long-Term Debt|Long-Term Liabilities AIM|ADTX: Company Long-Term Debts|GRI Bio Inc - Company Long-Term Loans and Borrowings|XRTX (XORTX) - Company Long-Term Debts|Company Long-Term Debts Vyome Therapeutics|Company Long-Term Debt Revelation Biosciences (REVB)|INDP (indaptusrx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Scinai Immunotherapeutics Ltd. SCNI|CALI - Company Long-Term Liabilities|Affimed Therapeutics - Company Long-Term Debts|ALLK - Company Long-Term Debts|HOOK (hookipapharma.com) - Company Long-Term Liabilities|IGM Biosciences - Company Long-Term Loans and Borrowings|ITOS (iTeos Therapeutics, Inc.) - Company Long-Term Debts|TC BioPharm (Holdings) Plc (TCBP) - Long-Term Debt Volume|Company Long-Term Debt Third Harmonic Bio, Inc (THRD)